Press Releases May 18, 2026 10:00 AM

Willis announces Corporate Risk & Broking North America growth leadership appointments

Willis Towers Watson strengthens North America Corporate Risk & Broking growth leadership with key appointments

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
WTW

Willis Towers Watson (WTW) announced strategic leadership hires in North America to bolster its Corporate Risk & Broking growth platform. Michael Butch joins as Growth Operations Leader, bringing expertise in sales analytics, while Jim Blaney is appointed Growth Enablement Leader with a focus on sales execution and client retention. Both will join existing leader Brian Hetherington, reporting to Chief Growth Officer Paul Graziano, aiming to accelerate growth and client engagement.

Willis announces Corporate Risk & Broking North America growth leadership appointments
WTW
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Michael Butch appointed as Growth Operations Leader for North America to enhance sales pipeline development and recruitment.
  • Jim Blaney named Growth Enablement Leader, focusing on tools and capabilities to support business generation and client retention.
  • These appointments aim to strengthen Willis Towers Watson's growth platform and client engagement in Corporate Risk & Broking across North America.

NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Willis, a WTW business (NASDAQ: WTW), today announced new leadership appointments designed to strengthen its growth platform across Corporate Risk & Broking North America.

Michael Butch joins the business as Growth Operations Leader for North America. In this newly created role, he will drive alignment, efficiency and consistency across growth initiatives to help accelerate pipeline development and conversion, Request for Proposal (RFP) adoption and recruitment. Butch brings more than 20 years of experience in sales analytics, financial analysis and data-driven decision-making. He joins Willis from Marsh, where he most recently served as North American Sales Analytics and Insights Lead.

Jim Blaney has been appointed Growth Enablement Leader, North America, effective immediately. In this role, he will focus on equipping teams with the tools, insights and capabilities needed to support new business generation, client retention and disciplined sales execution. Blaney has held multiple leadership positions throughout his career at WTW and most recently served as Head of Sales and Client Management. He brings deep expertise in organic growth, disciplined sales execution and specialization-led strategies.

Butch and Blaney join Brian Hetherington, Strategic Growth Leader, North America, as part of the North America Growth leadership team, reporting to Paul Graziano, Chief Growth Officer for Willis. Together, the team will work to accelerate growth and strengthen client engagement across North America.

“These appointments mark another step in building a stronger, more connected growth platform across North America,” said Graziano. “Mike, Jim and Brian bring deep expertise, trusted leadership and a strong commitment to culture and community – key reasons clients choose WTW and continue to grow with us over the long term.”

About WTW

At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance.

Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success - and provide perspective that moves you.

Media contacts

Lauren Ryan
Lauren.Ryan@wtwco.com

Arnelle Sullivan
Arnelle.Sullivan@wtwco.com


Risks

  • Execution risk in integrating new leadership roles effectively within existing teams which could delay growth initiatives.
  • Competitive pressure in the Corporate Risk & Broking sector could impact the effectiveness of growth strategies.
  • Macroeconomic or regulatory changes in North America that might influence client demand for risk and broking services.

More from Press Releases

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026